Global Next Generation Sequencing Market - Forecasts to 2016 - WDRB 41 Louisville News

Global Next Generation Sequencing Market - Forecasts to 2016

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, February 6, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/glj79b/global_next) has announced the addition of the "Global Next Generation Sequencing Market - Forecasts to 2016" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

With the expansion of the customer base to less sophisticated customers, access to improved bioinformatics tools is becoming even more of a priority. Sequencing companies started to seriously tackle this issue: in 2012 Life Technologies unveiled Ion Reporter, a commercial cloud-based variant analysis software package and purchased Compendia Bioscience. Illumina launched BaseSpace Apps, a dedicated application store for BaseSpace, its genomics cloud computing platform. In addition, Illumina secured the buy-in of bioinformatics companies such as Golden Helix, Biomatters, Ingenuity, Station X, and Spiral Genetics, on top of collaborations with Diagnomics, Ingenuity, and Knome.

According to the report, the growth of the Global Next-generation Sequencing market is driven by several factors, the most important of which is the increased adoption of next-generation sequencing technology by new customers.

Further, the report states that one of the key challenges in the market is the low adoption of genomic technology compared to other sequence analysis technologies, especially among large biotechnology companies. This is mainly because of logistical problems such as instrument complexity, problems in data storage, automation, and sample preparation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Key Topics Covered:

1. Executive Summary
2. Scope of the Report
3. Market Research Methodology
4. List of Abbreviations
5. Introduction
6. Market Landscape
7. Market Segmentation by Application
8. Market Segmentation by Technology
9. Market Segmentation by Product
10. Market Segmentation by End-users

11. Geographical Segmentation

12. Key Leading Countries

13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape

21. Key Vendor Analysis

22. Other Reports in this Series




Companies Mentioned:

  • 23andMe Inc.
  • Ambry Genetics Corp.
  • Axeq Technologies Inc.
  • Beijing Genomics Institute
  • Fluidigm Corp.
  • Foundation Medicine Inc.
  • GeneDx
  • Good Start Genetics Inc.
  • Helicos BioSciences Corp.
  • Illumina Inc.
  • Knome Inc.
  • Life Technologies Corp.
  • NABsys Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California Inc.
  • Pathogenica Inc.
  • QIAGEN N.V
  • RainDance Technologies Inc.
  • Roche Holding AG
  • Sequenom Inc.
  • Takara Bio Inc.


For more information visit http://www.researchandmarkets.com/research/glj79b/global_next


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WDRB. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.